Leading Exporters, Wholesaler and Trader of Molnunat 200mg Molnupiravir Capsules, Pangraf 0.5mg Tacrolimus Capsules, Pregarica 300 Pregabalin Capsules and Tacrograf 0.25mg Tacrolimus Capsules from Thane.
Indication: Treatment of mild to moderate COVID-19
Active Ingredient: Molnupiravir 200mg
Drug Class: Antiviral
Administration: Oral, as prescribed by a doctor
Side Effects: Headache, nausea, dizziness
Precaution: Not recommended for pregnant women, liver/kidney disease patients
Storage: Store at room temperature, away from moisture and light
Molnunat 200mg contains Molnupiravir, an oral antiviral medication used for the treatment of mild to moderate COVID-19 in high-risk adults to prevent severe illness and hospitalization. It works by inhibiting viral replication, reducing the spread of the virus in the body. Manufactured by Natco Pharma Ltd, Molnunat 200mg comes in 40-capsule packaging and should be taken as prescribed by a doctor. Common side effects include headache, nausea, and dizziness. This medication is not a substitute for vaccination and should be used only under medical supervision. Not recommended for pregnant women or individuals with severe liver or kidney disease.
Indicated For: Prevention of organ transplant rejection
Active Ingredient: Tacrolimus 0.5mg
Mechanism of Action: Suppresses immune response to prevent rejection
Dosage Form: Oral capsule
Benefits: Ensures long-term graft survival
Administration: Taken under medical supervision
Monitoring Required: Kidney function, blood pressure, drug levels
Pangraf 0.5mg contains Tacrolimus (0.5mg), an immunosuppressant used to prevent organ transplant rejection in kidney, liver, and heart recipients. It works by suppressing the immune system, reducing the risk of the body attacking the transplanted organ. Pangraf 0.5mg is also used in autoimmune conditions as prescribed by doctors. It must be taken under strict medical supervision, with regular monitoring of kidney function, blood pressure, and drug levels in the blood. Patients should follow dietary and lifestyle precautions to optimize effectiveness and minimize side effects. This medicine plays a vital role in ensuring long-term transplant success.
Indication: Prevents organ rejection post-transplant
Active Ingredient: Tacrolimus 0.25mg
Mechanism of Action: Suppresses T-cell activation to prevent immune response
Dosage Form: Capsule (Oral)
Administration: Taken twice daily, as prescribed
Side Effects: Hypertension, kidney issues, increased infection risk
Precaution: Requires regular monitoring of blood levels
Tacrograf 0.25mg contains Tacrolimus (0.25mg), a potent immunosuppressant derived from Streptomyces tsukubaensis. It is used primarily to prevent organ rejection in patients who have undergone liver, kidney, heart, and other organ transplants. Tacrograf works by inhibiting T-lymphocyte activation, thereby reducing the risk of the immune system attacking the transplanted organ. It is also effective in treating severe atopic dermatitis when used topically. The medication is available in capsule form and should be taken exactly as prescribed by a healthcare professional. Common side effects include hypertension, kidney dysfunction, and an increased risk of infections due to immune suppression.
